Advertisement
Research Article| Volume 324, ISSUE 1-2, P124-130, January 15, 2013

Midlife vascular risk factors and their association with dementia deaths: Results from a Norwegian prospective study followed up for 35years

  • Bjørn Heine Strand
    Correspondence
    Corresponding author. Tel.: +47 99005286.
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway
    Search for articles by this author
  • Ellen Melbye Langballe
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway
    Search for articles by this author
  • Vidar Hjellvik
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway
    Search for articles by this author
  • Marte Handal
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway
    Search for articles by this author
  • Øyvind Næss
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway

    Institute of Health and Society, University of Oslo, Norway
    Search for articles by this author
  • Gunn Peggy Knudsen
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway
    Search for articles by this author
  • Helga Refsum
    Affiliations
    Department of Nutrition, University of Oslo, Norway
    Search for articles by this author
  • Kristian Tambs
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway
    Search for articles by this author
  • Per Nafstad
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway

    Institute of Health and Society, University of Oslo, Norway
    Search for articles by this author
  • Henrik Schirmer
    Affiliations
    Department of Clinical Medicine, University of Tromsø, Norway
    Search for articles by this author
  • Astrid Liv Mina Bergem
    Affiliations
    Akershus University Hospital, Norway
    Search for articles by this author
  • Randi Selmer
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway
    Search for articles by this author
  • Knut Engedal
    Affiliations
    Norwegian Centre for Ageing and Health, Oslo University Hospital, Norway
    Search for articles by this author
  • Per Magnus
    Affiliations
    Norwegian Institute of Public Health, Marcus Thranes gt 6, 0473 Oslo, Norway

    Institute of Health and Society, University of Oslo, Norway
    Search for articles by this author
  • Espen Bjertness
    Affiliations
    Institute of Health and Society, University of Oslo, Norway

    Tibet University Medical College, Lhasa, Tibet, China
    Search for articles by this author
  • The GENIDEM-Group
    Author Footnotes
    1 Espen Bjertness (University of Oslo), Per Nafstad (University of Oslo), Per Magnus (University of Oslo and Norwegian Institute of Public Health), Kristian Tambs (Norwegian Institute of Public Health), Gun Peggy Knudsen (Norwegian Institute of Public Health), Mina Bergem (Akershus University Hospital), Knut Engedal (Oslo University Hospital), Øyvind Næss (Norwegian Institute of Public Health), Marte Handal (Norwegian Institute of Public Health), Gun Peggy Knudsen (Norwegian Institute of Public Health), Vidar Hjellvik (Norwegian Institute of Public Health), Randi Selmer (Norwegian Institute of Public Health), Bjørn Heine Strand (Norwegian Institute of Public Health), Lars Lannfelt (Uppsala University), Grethe Tell (University of Bergen), Helga Refsum (University of Oslo), Jostein Holmen (NTNU); Henrik Schirmer (University of Tromsø); Srdjan Djurovic (Oslo University Hospital), Miia Kivipelto (Karolinska Institute).
  • Author Footnotes
    1 Espen Bjertness (University of Oslo), Per Nafstad (University of Oslo), Per Magnus (University of Oslo and Norwegian Institute of Public Health), Kristian Tambs (Norwegian Institute of Public Health), Gun Peggy Knudsen (Norwegian Institute of Public Health), Mina Bergem (Akershus University Hospital), Knut Engedal (Oslo University Hospital), Øyvind Næss (Norwegian Institute of Public Health), Marte Handal (Norwegian Institute of Public Health), Gun Peggy Knudsen (Norwegian Institute of Public Health), Vidar Hjellvik (Norwegian Institute of Public Health), Randi Selmer (Norwegian Institute of Public Health), Bjørn Heine Strand (Norwegian Institute of Public Health), Lars Lannfelt (Uppsala University), Grethe Tell (University of Bergen), Helga Refsum (University of Oslo), Jostein Holmen (NTNU); Henrik Schirmer (University of Tromsø); Srdjan Djurovic (Oslo University Hospital), Miia Kivipelto (Karolinska Institute).
Published:November 12, 2012DOI:https://doi.org/10.1016/j.jns.2012.10.018

      Abstract

      There is growing evidence that midlife risk factors for vascular disease also are risk factors for dementia, but there is still need for long-term observational studies to address this. Our objective was to investigate the association of midlife vascular disease risk factors with dementia death. Participants were included in The Norwegian Counties Study (NCS) in the period 1974–78, aged 35–50 years at baseline. Information from NCS was linked with the Cause of Death Registry through the year 2009 using the unique personal identification number. The study included 48,793 participants, 1.5 million person years and 486 dementia deaths (187 Alzheimer's; 299 non-Alzheimer's dementia). Cox regression for cause-specific hazards was used. Dementia death was associated with increased total cholesterol levels (>7.80 vs. <5.20 mmol/l: HR=2.01, 95% confidence interval 1.37–2.93); diabetes (HR=2.43, 95% CI 1.40–4.32) and low body mass index (<20 kg/m2 vs. 20–25 kg/m2: HR=1.76, 95% CI 1.15–2.68) in midlife. The associations remained after adjustment for other vascular risk factors and educational level. Smoking status or blood pressure in midlife was not significantly associated with risk of dementia death, although the results indicate a possible increased risk in heavy smokers. People suffering from high cholesterol levels, diabetes or underweight in midlife are at increased risk of dying from or with dementia later in life. Our findings add to previous results suggesting that intervention in midlife may be important. To better understand the mechanisms involved in the associations between midlife underweight, diabetes, and elevated cholesterol level and late-life dementia death, these links need to be further investigated.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Daviglus M.L.
        • Bell C.C.
        • Berrettini W.
        • Bowen P.E.
        • Connolly E.S.
        • Cox N.J.
        • et al.
        National Institutes of Health state-of-the-science conference statement: preventing Alzheimer's disease and cognitive decline. Report no.: 27 (4).2010
        • Hughes T.F.
        • Ganguli M.
        Modifiable midlife risk factors for late-life cognitive impairment and dementia.
        Curr Psychiatry Rev. 2009; 5: 73-92
        • Prince M.
        • Jackson J.
        World Alzheimer report 2009.
        Alzheimer's Disease International, 2009
        • SHDir
        Glemsk, men ikke glemt.
        Om dagens situasjon og fremtidens utfordringer for å styrke tjenestetilbudet til personer med demens. Sosial- og helsedirektoratet, Oslo2007
        • Qiu C.
        • De R.D.
        • Fratiglioni L.
        The epidemiology of the dementias: an update.
        Curr Opin Psychiatry. 2007; 20: 380-385
        • Ince P.G.
        • McArthur F.K.
        • Bjertness E.
        • Torvik A.
        • Candy J.M.
        • Edwardson J.A.
        Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions.
        Dementia. 1995; 6: 162-168
        • Tolppanen A.M.
        • Solomon A.
        • Soininen H.
        • Kivipelto M.
        Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies.
        J Alzheimers Dis. Jan 1 2012; 32: 531-540
        • Qiu C.
        • Winblad B.
        • Fratiglioni L.
        The age-dependent relation of blood pressure to cognitive function and dementia.
        Lancet Neurol. 2005; 4: 487-499
        • de la Torre J.C.
        Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics.
        Lancet Neurol. 2004; 3: 184-190
        • Dickstein D.L.
        • Walsh J.
        • Brautigam H.
        • Stockton Jr., S.D.
        • Gandy S.
        • Hof P.R.
        Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.
        Mt Sinai J Med. 2010; 77: 82-102
        • Alonso A.
        • Mosley Jr., T.H.
        • Gottesman R.F.
        • Catellier D.
        • Sharrett A.R.
        • Coresh J.
        Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study.
        J Neurol Neurosurg Psychiatry. 2009; 80: 1194-1201
        • van Vliet P.
        • Westendorp R.G.
        • van H.D.
        • de Craen A.J.
        • Oleksik A.M.
        Cognitive decline precedes late-life longitudinal changes in vascular risk factors.
        J Neurol Neurosurg Psychiatry. 2010; 81: 1028-1032
        • Bjartveit K.
        The cardiovascular disease study in Norwegian counties.
        Statens Skjermbildefotografering (The National Mass Radiography Service), Oslo1983
        • European Atherosclerosis Society
        Cholesterol level cut-off scores.
        ([full pdf 2012 February 2Available from: URL: http://eurheartj.oxfordjournals.org/content/9/5/571.full.pdf])
        • Alonso A.
        • Jacobs Jr., D.R.
        • Menotti A.
        • Nissinen A.
        • Dontas A.
        • Kafatos A.
        • et al.
        Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study.
        J Neurol Sci. 2009; 280: 79-83
        • Kivipelto M.
        • Ngandu T.
        • Fratiglioni L.
        • Viitanen M.
        • Kareholt I.
        • Winblad B.
        • et al.
        Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.
        Arch Neurol. 2005; 62: 1556-1560
        • Solomon A.
        • Kivipelto M.
        • Wolozin B.
        • Zhou J.
        • Whitmer R.A.
        Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later.
        Dement Geriatr Cogn Disord. 2009; 28: 75-80
        • van Vliet P.
        • van de Water W.
        • de Craen A.J.
        • Westendorp R.G.
        The influence of age on the association between cholesterol and cognitive function.
        Exp Gerontol. 2009; 44: 112-122
        • van Vliet P.
        Cholesterol and late-life cognitive decline.
        J Alzheimers Dis. 2012; 30: 147-162
        • Kronzon I.
        • Tunick P.A.
        Aortic atherosclerotic disease and stroke.
        Circulation. 2006; 114: 63-75
        • McGuinness B.
        • O'Hare J.
        • Craig D.
        • Bullock R.
        • Malouf R.
        • Passmore P.
        Statins for the treatment of dementia.
        Cochrane Database Syst Rev. 2010; : CD007514
        • Sakshaug S.
        • Strøm H.
        • Blix H.
        • Litleskare I.
        • Rønning M.
        • Granum T.
        Drug consumption in Norway 2007–2011.
        Report No.: 2012:1. Norwegian Institute of Public Health, 2012
        • Sharp S.I.
        • Aarsland D.
        • Day S.
        • Sonnesyn H.
        • Ballard C.
        Hypertension is a potential risk factor for vascular dementia: systematic review.
        Int J Geriatr Psychiatry. 2011; 26: 661-669
        • Sahathevan R.
        • Brodtmann A.
        • Donnan G.A.
        Dementia, stroke, and vascular risk factors; a review.
        Int J Stroke. 2012; 7: 61-73
        • Guan J.W.
        • Huang C.Q.
        • Li Y.H.
        • Wan C.M.
        • You C.
        • Wang Z.R.
        • et al.
        No association between hypertension and risk for Alzheimer's disease: a meta-analysis of longitudinal studies.
        J Alzheimers Dis. 2011; 27: 799-807
        • Power M.C.
        • Weuve J.
        • Gagne J.J.
        • McQueen M.B.
        • Viswanathan A.
        • Blacker D.
        The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis.
        Epidemiology. 2011; 22: 646-659
        • Ronnemaa E.
        • Zethelius B.
        • Lannfelt L.
        • Kilander L.
        Vascular risk factors and dementia: 40-year follow-up of a population-based cohort.
        Dement Geriatr Cogn Disord. 2011; 31: 460-466
        • Cataldo J.K.
        • Prochaska J.J.
        • Glantz S.A.
        Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation.
        J Alzheimers Dis. 2010; 19: 465-480
        • Anstey K.J.
        • von S.C.
        • Salim A.
        • O'Kearney R.
        Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies.
        Am J Epidemiol. 2007; 166: 367-378
        • Kivipelto M.
        • Rovio S.
        • Ngandu T.
        • Kareholt I.
        • Eskelinen M.
        • Winblad B.
        • et al.
        Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study.
        J Cell Mol Med. 2008; 12: 2762-2771
        • Rosengren A.
        • Skoog I.
        • Gustafson D.
        • Wilhelmsen L.
        Body mass index, other cardiovascular risk factors, and hospitalization for dementia.
        Arch Intern Med. 2005; 165: 321-326
        • Rusanen M.
        • Kivipelto M.
        • Quesenberry Jr., C.P.
        • Zhou J.
        • Whitmer R.A.
        Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia.
        Arch Intern Med. 2011; 171: 333-339
        • Aarsland D.
        • Sardahaee F.S.
        • Anderssen S.
        • Ballard C.
        Is physical activity a potential preventive factor for vascular dementia? A systematic review.
        Aging Ment Health. 2010; 14: 386-395
        • Ahlskog J.E.
        • Geda Y.E.
        • Graff-Radford N.R.
        • Petersen R.C.
        Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging.
        Mayo Clin Proc. 2011; 86: 876-884
        • Anstey K.J.
        • Cherbuin N.
        • Budge M.
        • Young J.
        Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.
        Obes Rev. 2011; 12: e426-e437
        • Gustafson D.R.
        • Backman K.
        • Joas E.
        • Waern M.
        • Ostling S.
        • Guo X.
        • et al.
        37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden.
        J Alzheimers Dis. 2012; 28: 163-171
        • Ives D.G.
        • Samuel P.
        • Psaty B.M.
        • Kuller L.H.
        Agreement between nosologist and cardiovascular health study review of deaths: implications of coding differences.
        J Am Geriatr Soc. 2009; 57: 133-139
        • Bjertness E.
        • Torvik A.
        • Ince P.G.
        • Edwardson J.A.
        Validation of Norwegian death certificates on dementia in residents of nursing homes.
        Epidemiology. 1998; 9: 584-586
        • Ott A.
        • Breteler M.M.
        • van H.F.
        • Claus J.J.
        • van der Cammen T.J.
        • Grobbee D.E.
        • et al.
        Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study.
        BMJ. 1995; 310: 970-973
        • Andersen P.K.
        • Geskus R.B.
        • de W.T.
        • Putter H.
        Competing risks in epidemiology: possibilities and pitfalls.
        Int J Epidemiol. 2012; 41: 861-870